Nonadrenergic Drugs Improve Cognition, Apathy in Alzheimer Disease - Neurology Advisor

Researchers sought to evaluate the efficacy of noradrenergic drugs in the improvement of neuropsychiatric and cognitive symptoms in individuals with AD.

The use of pharmacotherapies that target the noradrenergic system has been shown to improve cognition and apathy among patients with dementia or mild cognitive impairment (MCI) associated with Alzhei… [+2927 chars]

full article...